Related references
Note: Only part of the references are listed.Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance
Stacy Loeb et al.
JOURNAL OF UROLOGY (2019)
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
Hyung L. Kim et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator
Giorgio Gandaglia et al.
BJU INTERNATIONAL (2018)
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Matthew R. Cooperberg et al.
EUROPEAN UROLOGY (2018)
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Daniel E. Spratt et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy
Hiten D. Patel et al.
JOURNAL OF UROLOGY (2018)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
Martin G. Sanda et al.
JOURNAL OF UROLOGY (2018)
National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
Monty A. Aghazadeh et al.
JOURNAL OF UROLOGY (2018)
Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer
Selma Masic et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Genomic biomarkers in prostate cancer
Zachary Kornberg et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2018)
The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies
Jonathan S. Brajtbord et al.
EUROPEAN UROLOGY (2017)
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
Eric A. Klein et al.
JOURNAL OF UROLOGY (2017)
Whom to Treat Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier
Annika Herlemann et al.
UROLOGIC CLINICS OF NORTH AMERICA (2017)
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
Guido Sauter et al.
EUROPEAN UROLOGY (2016)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2016)
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
Ashley E. Ross et al.
EUROPEAN UROLOGY (2016)
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens
Beatrice S. Knudsen et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru et al.
JOURNAL OF UROLOGY (2016)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Risk Group and Death From Prostate Cancer Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer
Ann C. Raldow et al.
JAMA ONCOLOGY (2015)
Correcting for Optimistic Prediction in Small Data Sets
Gordon C. S. Smith et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy
Zachary S. Zumsteg et al.
EUROPEAN UROLOGY (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
The Quantitative Gleason Score Improves Prostate Cancer Risk Assessment
Adam C. Reese et al.
CANCER (2012)
Minimal Impact of Clinical Stage on Prostate Cancer Prognosis Among Contemporary Patients With Clinically Localized Disease
Adam C. Reese et al.
JOURNAL OF UROLOGY (2010)
Gleason Score and Lethal Prostate Cancer: Does 3+4=4+3?
Jennifer R. Stark et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
Matthew R. Cooperberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Share Paper
